{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:59:33Z","timestamp":1790805573353,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302586"],"award-info":[{"award-number":["82302586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270658"],"award-info":[{"award-number":["82270658"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.122854","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:24:52Z","timestamp":1790519092000},"page":"122854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Machine learning-based discrimination of metabolic dysfunction-associated steatotic liver disease: implications of tryptophan metabolites as potential biomarkers"],"prefix":"10.1016","volume":"594","author":[{"given":"Zhenni","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nijiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichen","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.cca.2026.122854_bb0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.cca.2026.122854_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease","volume":"19","author":"Eslam","year":"2025","journal-title":"Hepatol. Int."},{"issue":"4","key":"10.1016\/j.cca.2026.122854_bb0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cca.2026.122854_bb0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.cca.2026.122854_bb0030","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13679-025-00673-5","article-title":"Beyond discrete diagnoses: conceptualizing obesity-associated metabolic disorders as a unified, dynamic continuum","volume":"14","author":"Xie","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.cca.2026.122854_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120787","article-title":"Diagnostic performance of non-invasive markers for distinguishing MASLD\/MASH: insights from meta-analysis and real-world data","author":"Patil","year":"2026","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.cca.2026.122854_bb0045","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2024.10.015","article-title":"A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease","volume":"82","author":"Huang","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.122854_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"10.1016\/j.cca.2026.122854_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"10.1016\/j.cca.2026.122854_bb0060","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and nutrition examination survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.cca.2026.122854_bb0070","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-020-01756-1","article-title":"Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis","volume":"17","author":"Masarone","year":"2021","journal-title":"Metabolomics"},{"issue":"4","key":"10.1016\/j.cca.2026.122854_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3350\/cmh.2021.0127","article-title":"Recent advances in nonalcoholic fatty liver disease metabolomics","volume":"27","author":"Kim","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cca.2026.122854_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2026.113067","article-title":"Integrated metabolomics and machine learning identify potential biomarkers and metabolism-related targets for MASLD in older adults","author":"Jin","year":"2026","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0085","article-title":"Blood metabolic panels for identifying significant fibrosis and inflammation in patients with MASLD","volume":"7","author":"Huang","year":"2026","journal-title":"Cell Rep. Med."},{"issue":"14","key":"10.1016\/j.cca.2026.122854_bb0090","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.122854_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.cca.2026.122854_bb0100","doi-asserted-by":"crossref","DOI":"10.2196\/36997","article-title":"Noninvasive diagnosis of nonalcoholic steatohepatitis and advanced liver fibrosis using machine learning methods: comparative study with existing quantitative risk scores","volume":"10","author":"Wu","year":"2022","journal-title":"JMIR Med. Inform."},{"issue":"4","key":"10.1016\/j.cca.2026.122854_bb0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.14172","article-title":"Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population","volume":"46","author":"Yip","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.cca.2026.122854_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10060229","article-title":"Recommendations and best practices for standardizing the pre-analytical processing of blood and urine samples in metabolomics","volume":"10","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2020","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24795","article-title":"Evaluation of characteristic metabolites of aromatic amino acids in patients with HIV infection at different stages of disease","volume":"37","author":"Yuan","year":"2023","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/acs.jproteome.7b00518","article-title":"Long-term stability of human plasma metabolites during storage at \u221280\u00b0C","volume":"17","author":"Haid","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2026.122854_bb0125","article-title":"Abnormal kynurenine-pathway metabolites in gout: biomarkers exploration based on orthogonal partial least squares-discriminant analysis","author":"Liu","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.cca.2026.122854_bb0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s43587-025-00818-0","article-title":"Large-scale proteomic analyses of incident Parkinson\u2019s disease reveal new pathophysiological insights and potential biomarkers","volume":"5","author":"Gan","year":"2025","journal-title":"Nat. Aging"},{"issue":"25","key":"10.1016\/j.cca.2026.122854_bb0135","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.122854_bb0140","article-title":"Altered neopterin and IDO in kynurenine metabolism based on LC-MS\/MS metabolomics study: novel therapeutic checkpoints for type 2 diabetes mellitus","author":"Liu","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.cca.2026.122854_bb0145","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.cca.2026.122854_bb0150","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.cca.2026.122854_bb0155","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2147\/DMSO.S356371","article-title":"Lipid-lowering responses to dyslipidemia determine the efficacy on liver enzymes in metabolic dysfunction-associated fatty liver disease with hepatic injuries: a prospective cohort study","volume":"15","author":"Liao","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"12","key":"10.1016\/j.cca.2026.122854_bb0160","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"21","key":"10.1016\/j.cca.2026.122854_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111905","article-title":"Clinical and molecular biomarkers for diagnosis and staging of NAFLD","volume":"22","author":"Di Mauro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cca.2026.122854_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05230-22","article-title":"Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children","volume":"12","author":"Luo","year":"2024","journal-title":"Microbiol. Spectrum"},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41522-025-00706-w","article-title":"Targeted metabolomics reveals bioactive inflammatory mediators from gut into blood circulation in children with NAFLD","volume":"11","author":"Luo","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"5","key":"10.1016\/j.cca.2026.122854_bb0180","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0470","article-title":"Identification of tryptophan metabolism-related biomarkers for nonalcoholic fatty liver disease through network analysis","volume":"14","author":"Jiang","year":"2025","journal-title":"Endocr. Connect."},{"issue":"2","key":"10.1016\/j.cca.2026.122854_bb0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.21037\/atm-20-3594","article-title":"A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases","volume":"9","author":"Zhou","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cca.2026.122854_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/11786469211070533","article-title":"Intestinal dysbiosis, the tryptophan pathway and nonalcoholic steatohepatitis","author":"Chen","year":"2022","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.cca.2026.122854_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1246518","article-title":"Sex, age, and BMI modulate the association of physical examinations and blood biochemistry parameters and NAFLD: a retrospective study on 1994 cases observed at Shuguang hospital, China","author":"Tang","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.cca.2026.122854_bb0200","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2016-3440","article-title":"Association of NAFLD with diabetes and the impact of BMI changes: a 5-year cohort study based on 18,507 elderly","volume":"102","author":"Liu","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0205","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12967-023-04047-0","article-title":"Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis","volume":"21","author":"Lu","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12889-026-26316-5","article-title":"Prognostic value of non-invasive fibrosis assessment scores in predicting mortality among individuals with metabolic dysfunction-associated steatotic liver disease","volume":"26","author":"Wu","year":"2026","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1016\/j.cca.2026.122854_bb0215","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep4.1188","article-title":"Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: results from discovery and validation cohorts","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol. Commun."},{"issue":"10","key":"10.1016\/j.cca.2026.122854_bb0220","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","article-title":"Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids","volume":"56","author":"Ore\u0161i\u010d","year":"2013","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.cca.2026.122854_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70056","article-title":"Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development","volume":"17","author":"Ponce-Bobadilla","year":"2024","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"17","key":"10.1016\/j.cca.2026.122854_bb0240","doi-asserted-by":"crossref","first-page":"21309","DOI":"10.18632\/aging.203460","article-title":"Activation of the gut microbiota-kynurenine-liver axis contributes to the development of nonalcoholic hepatic steatosis in nondiabetic adults","volume":"13","author":"Sui","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"10.1016\/j.cca.2026.122854_bb0245","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-018-0060-4","article-title":"Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health","volume":"24","author":"Laurans","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2026.122854_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2025.110174","article-title":"High-fat diet mediates the formation of nonalcoholic fatty liver by modulating the AhR\/miR-132\/SIRT1 axis","author":"Tao","year":"2026","journal-title":"J. Nutr. Biochem."},{"issue":"7","key":"10.1016\/j.cca.2026.122854_bb0255","article-title":"Neopterin, inflammation, and oxidative stress: what could we be missing?","volume":"7","author":"Gieseg","year":"2018","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.cca.2026.122854_bb0260","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/157016111794519372","article-title":"Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology","volume":"9","author":"De Rosa","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.cca.2026.122854_bb0265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/met.2020.0144","article-title":"Neopterin in the evolution from obesity to prediabetes and newly diagnosed type 2 diabetes","volume":"19","author":"Nedeva","year":"2021","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"9","key":"10.1016\/j.cca.2026.122854_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/biology14091157","article-title":"Neopterin concentration in umbilical cord blood as a reflection of maternal insulin resistance-A pilot study","volume":"14","author":"Ch\u0119ci\u0144ska-Kope\u0107","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.cca.2026.122854_bb0275","doi-asserted-by":"crossref","DOI":"10.1177\/11786469261423510","article-title":"Altered tryptophan-kynurenine pathway and low-grade inflammation in metabolic dysfunction-associated steatotic liver disease (MASLD): insights from LC-MS\/MS-based metabolite profiling","author":"\u00dcnal","year":"2026","journal-title":"Int. J. Tryptophan Res."},{"issue":"3","key":"10.1016\/j.cca.2026.122854_bb0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09674845.2009.11730261","article-title":"Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity","volume":"66","author":"Abdou","year":"2009","journal-title":"Br. J. Biomed. Sci."},{"issue":"11\u221212","key":"10.1016\/j.cca.2026.122854_bb0285","first-page":"1141","article-title":"Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents","volume":"26","author":"Arslan","year":"2013","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.122854_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120051","article-title":"Amelioration of hydrolyzed guar gum on high-fat diet-induced obesity: integrated hepatic transcriptome and metabolome","author":"Fu","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.cca.2026.122854_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07287-7","article-title":"Serotonin signals through a gut-liver axis to regulate hepatic steatosis","volume":"9","author":"Choi","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cca.2026.122854_bb0300","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41366-018-0047-8","article-title":"Augmented capacity for peripheral serotonin release in human obesity","volume":"42","author":"Young","year":"2018","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.cca.2026.122854_bb0305","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.048922","article-title":"Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver","volume":"14","author":"Ko","year":"2021","journal-title":"Dis. Model. Mech."},{"issue":"3","key":"10.1016\/j.cca.2026.122854_bb0310","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/hep.30880","article-title":"Modulation of the tryptophan hydroxylase 1\/monoamine oxidase-A\/5-Hydroxytryptamine\/5-Hydroxytryptamine receptor 2A\/2B\/2C axis regulates biliary proliferation and liver fibrosis during cholestasis","volume":"71","author":"Kyritsi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.122854_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00557","article-title":"Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation","author":"Cussotto","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cca.2026.122854_bb0320","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1002\/jcp.30199","article-title":"Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK\/autophagy- and AMPK\/ORP150-mediated signaling","volume":"236","author":"Pyun","year":"2021","journal-title":"J. Cell. Physiol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812602036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812602036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:18:09Z","timestamp":1790803089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812602036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":64,"alternative-id":["S000989812602036X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.122854","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning-based discrimination of metabolic dysfunction-associated steatotic liver disease: implications of tryptophan metabolites as potential biomarkers","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.122854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122854"}}